Delivery Order SPE2DR25D9223-SPE2DR26FFAH4
- Not listed
- The Defense Logistics Agency issued a $7,309.20 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Lidocaine 5% Patch 30s. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $1,096.38, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $3,045.50, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 13, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $1,096.38, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 17, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $3,654.60, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL and...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Lidocaine 5% Patch 30s. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30S, with a ceiling value of $14,618.40. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's indefinite delivery contract vehicle authorizing firm fixed-price orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for lidocaine 5% patch 30-count units, with a ceiling value of $1,582.00. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations...
- The Defense Logistics Agency issued a $5,847.36 delivery order to DMS Pharmaceutical Group Inc. on February 19, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business. The order carries a firm fixed-price structure with an ultimate completion date of February 20, 2026. Place of performance is Park Ridge, IL 60068. PPV-G GEN V is the Defense Logistics Agency's single-award...
- The Defense Logistics Agency issued a $1,461.84 delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- SPE2DR25D9223Indefinite Delivery Contract
- SPE2DR25D9223-SPE2DR26FFAH4Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $4,385.52, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. The underlying IDC carries a $499.999 billion ceiling and an ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The delivery order is priced on a firm fixed-price basis with an ultimate completion date of April 27, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/23/26 |